PortfoliosLab logoPortfoliosLab logo
WDH vs. AQST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

WDH vs. AQST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Waterdrop Inc. (WDH) and Aquestive Therapeutics, Inc. (AQST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WDH achieves a -21.77% return, which is significantly higher than AQST's -37.62% return.


WDH

1D
-3.31%
1M
-7.59%
YTD
-21.77%
6M
-21.36%
1Y
2.75%
3Y*
-11.69%
5Y*
-28.24%
10Y*

AQST

1D
2.54%
1M
-4.50%
YTD
-37.62%
6M
-34.47%
1Y
26.73%
3Y*
21.26%
5Y*
1.72%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WDH vs. AQST - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WDH
Waterdrop Inc.
-21.77%66.25%19.17%-68.77%141.30%-85.77%
AQST
Aquestive Therapeutics, Inc.
-37.62%81.46%76.24%123.92%-76.81%13.74%

Correlation

The correlation between WDH and AQST is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (All Time)
Calculated using the full available price history since May 10, 2021

0.09

The correlation between WDH and AQST shifts across timeframes, from 0.08 (5 years) to 0.20 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

WDH:

$54.11M

AQST:

$494.12M

EPS

WDH:

$2.18

AQST:

-$0.61

PS Ratio

WDH:

0.10

AQST:

9.11

Total Revenue (TTM)

WDH:

$3.96B

AQST:

$50.27M

Gross Profit (TTM)

WDH:

$2.02B

AQST:

$20.92M

EBITDA (TTM)

WDH:

$369.70M

AQST:

-$53.08M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDH vs. AQST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDH
WDH Risk / Return Rank: 4242
Overall Rank
WDH Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
WDH Sortino Ratio Rank: 4141
Sortino Ratio Rank
WDH Omega Ratio Rank: 3939
Omega Ratio Rank
WDH Calmar Ratio Rank: 4343
Calmar Ratio Rank
WDH Martin Ratio Rank: 4343
Martin Ratio Rank

AQST
AQST Risk / Return Rank: 5454
Overall Rank
AQST Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
AQST Sortino Ratio Rank: 5757
Sortino Ratio Rank
AQST Omega Ratio Rank: 6060
Omega Ratio Rank
AQST Calmar Ratio Rank: 5151
Calmar Ratio Rank
AQST Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDH vs. AQST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Waterdrop Inc. (WDH) and Aquestive Therapeutics, Inc. (AQST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WDHAQSTDifference

Sharpe ratio

Return per unit of total volatility

0.06

0.32

-0.25

Sortino ratio

Return per unit of downside risk

0.45

1.13

-0.67

Omega ratio

Gain probability vs. loss probability

1.05

1.17

-0.11

Calmar ratio

Return relative to maximum drawdown

0.10

0.44

-0.34

Martin ratio

Return relative to average drawdown

0.21

0.86

-0.65

WDH vs. AQST - Sharpe Ratio Comparison

The current WDH Sharpe Ratio is 0.06, which is lower than the AQST Sharpe Ratio of 0.32. The chart below compares the historical Sharpe Ratios of WDH and AQST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WDHAQSTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.06

0.32

-0.25

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.46

0.02

-0.48

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.48

-0.18

-0.29

Drawdowns

WDH vs. AQST - Drawdown Comparison

The maximum WDH drawdown since its inception was -90.62%, smaller than the maximum AQST drawdown of -96.68%. Use the drawdown chart below to compare losses from any high point for WDH and AQST.


Loading charts...

Drawdown Indicators


WDHAQSTDifference

Max Drawdown

Largest peak-to-trough decline

-90.62%

-96.68%

+6.06%

Max Drawdown (1Y)

Largest decline over 1 year

-26.97%

-60.61%

+33.64%

Max Drawdown (3Y)

Largest decline over 3 years

-62.60%

-63.55%

+0.95%

Max Drawdown (5Y)

Largest decline over 5 years

-89.26%

-90.11%

+0.85%

Current Drawdown

Current decline from peak

-83.38%

-78.74%

-4.64%

Average Drawdown

Average peak-to-trough decline

-80.12%

-76.96%

-3.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.15%

31.09%

-17.94%

Volatility

WDH vs. AQST - Volatility Comparison

The current volatility for Waterdrop Inc. (WDH) is 13.75%, while Aquestive Therapeutics, Inc. (AQST) has a volatility of 20.41%. This indicates that WDH experiences smaller price fluctuations and is considered to be less risky than AQST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WDHAQSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.75%

20.41%

-6.66%

Volatility (6M)

Calculated over the trailing 6-month period

25.24%

68.93%

-43.69%

Volatility (1Y)

Calculated over the trailing 1-year period

44.81%

86.21%

-41.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.93%

82.64%

-20.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

62.87%

87.78%

-24.91%

Dividends

WDH vs. AQST - Dividend Comparison

WDH's dividend yield for the trailing twelve months is around 4.11%, while AQST has not paid dividends to shareholders.


PositionTTM20252024
AQST
Aquestive Therapeutics, Inc.
0.00%0.00%0.00%
WDH
Waterdrop Inc.
4.11%2.63%5.08%

Financials

WDH vs. AQST - Financials Comparison

This section allows you to compare key financial metrics between Waterdrop Inc. and Aquestive Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B1.40B20222023202420252026
1.39B
14.45M
(WDH) Total Revenue
(AQST) Total Revenue
Values in USD except per share items

WDH vs. AQST - Profitability Comparison

The chart below illustrates the profitability comparison between Waterdrop Inc. and Aquestive Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
52.0%
0
Portfolio components
WDH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Waterdrop Inc. reported a gross profit of 723.78M and revenue of 1.39B. Therefore, the gross margin over that period was 52.0%.

AQST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 14.45M. Therefore, the gross margin over that period was 0.0%.

WDH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Waterdrop Inc. reported an operating income of 82.71M and revenue of 1.39B, resulting in an operating margin of 5.9%.

AQST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported an operating income of -4.20M and revenue of 14.45M, resulting in an operating margin of -29.1%.

WDH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Waterdrop Inc. reported a net income of 159.88M and revenue of 1.39B, resulting in a net margin of 11.5%.

AQST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a net income of -8.06M and revenue of 14.45M, resulting in a net margin of -55.8%.


Frequently Asked Questions


WDH and AQST have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AQST has higher volatility (20.41%) compared to WDH (13.75%). In terms of maximum drawdown, WDH dropped -90.62% vs AQST's -96.68%.

AQST currently has the higher Sharpe Ratio (0.32 vs 0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WDH and AQST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer